4D Molecular Therapeutics, Inc.
FDMTNASDAQHealthcare● Active
$8.64
+$0.00(+0.00%)
Market Cap$451666835
P/E Ratio—
52W High$12.34
52W Low$3.68
4D Molecular Therapeutics, Inc. (FDMT) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FDMT · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $402.65M | $424.88M | $288.23M | $213.55M | $247.78M |
| Net Receivables | $0.00M | $0.00M | $0.00M | $0.70M | $0.05M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $413.13M | $434.93M | $296.59M | $220.51M | $256.28M |
| PP&E Net | $33.01M | $40.61M | $31.66M | $35.35M | $28.95M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $566.71M | $560.38M | $339.89M | $261.85M | $353.49M |
| Liabilities | |||||
| Short-Term Debt | $5.59M | $0.00M | $0.00M | $2.65M | $0.00M |
| Accounts Payable | $11.16M | $4.39M | $3.52M | $3.32M | $4.76M |
| Total Current Liabilities | $43.98M | $29.15M | $18.95M | $15.73M | $16.34M |
| Long-Term Debt | $15.82M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $61.05M | $49.78M | $32.06M | $30.51M | $34.38M |
| Stockholders Equity | |||||
| Retained Earnings | ($716.30M) | ($576.20M) | ($415.33M) | ($314.49M) | ($207.00M) |
| Total Stockholders Equity | $505.66M | $510.61M | $307.83M | $231.34M | $319.11M |
| Total Liab & Equity(computed) | $566.71M | $560.38M | $339.89M | $261.85M | $353.49M |
| Debt Summary | |||||
| Total Debt | $21.41M | $24.61M | $14.67M | $16.12M | $16.45M |
| Net Debt | ($38.83M) | ($124.73M) | ($234.44M) | ($36.23M) | ($136.55M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more 4D Molecular Therapeutics, Inc. data
About 4D Molecular Therapeutics, Inc. (FDMT) Balance Sheet
4D Molecular Therapeutics, Inc. (FDMT) balance sheet shows total assets of $0.57B with cash of $0.40B. Total liabilities are $0.06B, total debt $0.02B, and stockholders equity $0.51B.
Frequently asked questions
FDMT · 4 questions4D Molecular Therapeutics, Inc. has total debt of $0.02B with net debt of ($0.04B).
FDMT total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10